-
Featured Authors
Business of Biotech
Archive
- April 2013 (1)
- February 2013 (2)
- January 2013 (1)
- October 2012 (1)
- September 2012 (3)
- August 2012 (1)
- January 2012 (3)
- December 2011 (2)
- October 2011 (3)
- August 2011 (3)
- July 2011 (2)
- June 2011 (12)
- April 2011 (2)
- January 2010 (1)
- November 2009 (1)
- October 2009 (47)
- September 2009 (37)
- August 2009 (1)
- June 2008 (3)
- May 2008 (2)
- April 2008 (1)
- February 2008 (6)
Category Archives: Business of Biotech
Race to Develop H1N1 Vaccine
Execs from Inovio Biomedical Corporation and Novavax will be speaking at BIF about their experience in the race to develop a vaccine for H1N1. Below are a couple recent developments from these companies: Novavax Inc (NVAX.O) recently reported that its seasonal flu vaccine candidate, which uses virus-like particles, induced an immune response against H3N2, H1N1 and B and was well-tolerated in a mid-stage trial. Read the release. Inovio Biomedical Corp. (INO) said it will team up Read More >
PTC Therapeutics Announces Collaboration with Roche
PTC Therapeutics, Inc. announced a research collaboration and licensing agreement with Roche for development of orally bioavailable small molecules using PTC’s technology, Gene Expression Modulation by Small-molecules (GEMS™). As part of the collaboration, Roche is paying PTC Therapeutics $12 million as part of an agreement to develop small molecule CNS disease drugs. Subject to meeting milestones, there is the potential for PTC to earn up to $239 million in research, development, regulatory and commercial milestone Read More >
Investor Perception Study Predicts Future of Biotech Sector
The BIO/Thomson Reuters Investor Perception Study is an in-depth assessment of Wall Street’s views of the biotech industry, its current challenges, its relative valuation, and the outlook for 2009. The analysis aims to provide BIO members with an insider’s perspective on what the investment community values in the current economic climate and help foster more effective communication between company management, shareholders, and potential investors.
MA Governor Deval Patrick to be Honored as BIO Governor of the Year
WHAT: The Biotechnology Industry Organization (BIO) will present Massachusetts Governor Deval Patrick with its Governor of the Year award in recognition of his leadership and support of the biosciences industry. WHEN: Tuesday, June 17, 2008, at 11:45 a.m. PDT WHERE: BIO 2008 International Convention San Diego Convention Center Upper Level, Ballroom 20 WHO: Joshua Boger, PhD, Chairman of BIO’s Board of Directors and President & CEO of Cambridge-based Vertex Pharmaceuticals Incorporated will present the award Read More >
BIO and Battelle to Present State-By-State Analysis of Bioscience Trends
WHAT: A comprehensive state-by-state analysis of bioscience initiatives in all 50 states and Puerto Rico. The report uses the most current and comparable annual data available to present national, state and metropolitan bioscience employment and growth trends. The report also examines other indicators of a state’s bioscience industry including R&D funding, venture capital investment, and patents. WHEN: Wednesday, June 18, 2008, 2 p.m. PDT WHERE: BIO 2008 International Convention San Diego Convention Center Press Corridor, Read More >
